{url={type=EXTERNAL, content_id=null, href=}, open_in_new_tab=false, no_follow=false}

RESKUE Trial for Patients with Krabbe Disease

By Forge Biologics
Jan 21, 2021 1:17:00 PM

RESKUE Trial for Patients with Krabbe Disease

With new beginnings comes new hope.  As we enter 2021, screening will begin for the our Phase 1/2 RESKUE trial – the first in-human gene therapy clinical trial for patients with Krabbe Disease.  Learn more about the RESKUE trial here: https://clinicaltrials.gov/ct2/show/NCT04693598?term=NCT04693598

 

5D4_8671